Linkedin Facebook
Main Menu
|
Join TPA

2023 ODP Health Alert -FDA Drug Safety Communication

ODP is sharing this Health Alert with stakeholders for awareness.

For more information, please see ODP Health Alert on  levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan) from the U.S. Food and Drug Administration. 

Share the Post:

Related Posts

TPA_ODP

ODPANN 23-101: Provider Qualification Process

December 8, 2023 No Comments
The Centers for Medicare and Medicaid Services (CMS) require a statewide process to ensure providers are qualified to render services to waiver-funded individuals. The Provider Qualification Process described in ODPANN 23-101 outlines the steps the Assigned AE and provider must follow to meet these requirements and the steps SCs ...
Read More →
TPA_ODP

Housing Myth Busting Survey- We Need Your Help!

December 8, 2023 No Comments
We need your help sharing this important survey on Housing out to all families, caregivers and individuals with disabilities!!! Please click here to download the pdf to ...
Read More →
TPA_ODP

ODPANN 23-071 Targeted Service Recovery and Expansion Supplemental Payments Update

December 6, 2023 No Comments
This announcement provides eligible providers with additional information about payments processed by ODP. For additional Information, please review ODPANN 23-071 (Updated).
Read More →

The Provider Alliance is a not-for-profit association for organizations providing supports to people with intellectual disability and their families.

Linkedin Facebook

The Provider Alliance

Join TPA

Join our mailing list

The Provider Alliance (TPA) membership delivers timely, relevant information that ID/A providers need to optimize their services, manage their businesses efficiently, and navigate a complex regulatory landscape.
Join Now for FREE!

©2025 ALL RIGHTS RESERVED

Created by Shoo.in Company